Manifestasi Gastrointestinal dan Peran Swab Anal pada COVID-19: Laporan Kasus dari Rumah Sakit Rujukan Tersier, Jakarta

Muhamad Rizqy Fadhillah, Jamal Zaini, Andika Chandra Putra, Fathiyah isbaniah, Muammar Emir Ananta, Ginindha Izzati Sabila

Abstract

Introduksi: Coronavirus Disease 2019 (COVID-19) merupakan penyakit infeksius yang masih menjadi permasalahan serius di dunia. Meskipun presentasi klinis utama COVID-19 adalah gejala respirasi, manifestasi gastrointestinal seperti nyeri perut dan diare dapat ditemukan sebagai satu-satunya presentasi dari penyakit ini. Swab anal dapat dilakukan untuk penegakkan diagnosis COVID-19 dengan presentasi gastrointestinal. Namun perananya dalam diagnosis COVID-19 masih belum diketahui secara pasti.

Laporan kasus: Laporan kasus ini membahas seorang pasien dewasa yang datang dengan keluhan gastrointestinal tanpa adanya gejala respirasi. Pasien ini kemudian terkonfirmasi COVID-19 melalui pemeriksaan polymerase chain reaction (PCR) pada sampel swab nasofaring dan swab anal.

Diskusi: COVID-19 dapat ditandai dengan berbagai gejala dari organ tubuh manapun, salah satunya adalah gejala gastrointestinal. Swab anal menjadi sampel yang cukup representatif dalam membantu penegakkan diagnosis COVID-19 dengan gejala gastrointestinal. 

Kesimpulan: Di tengah pandemi ini, presentasi gastrointestinal tanpa gejala respirasi perlu dipertimbangkan sebagai presentasi klinis atipikal dari COVID-19. Hal ini menuntut kehati-hatian tenaga kesehatan untuk menghindari misdiagnosis COVID-19 dengan menggunakan pengambilan sampel dari organ lain seperti swab anal.

Keywords

diagnosis; COVID-19; SARS-CoV-2; gejala gastrointestinal; swab anal

Full Text:

PDF

References

1. World Health Organization. Archived: WHO timeline–COVID-19 [Internet]. 2020 Apr 27 [cited 2021 Jun 15]. Available from https://www.who.int/news/item/27-04-2020-who-timeline---covid-19

2. World Health Organization. COVID-19 Weekly Epidemiological Update 15-17 august. 2021.

3. World Health Organization. WHO coronavirus (COVID-19) Indonesia dashboard [Internet]. 2021 Aug 23 [cited 2021 Jun 24]. Available from https://covid19.who.int/region/searo/country/id

4. Cha HM, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol. 2020 May 21;26(19):2323-32.

5. Syam AF. Gastrointestinal disorders in COVID-19 patients: a great imitator. Med J Indones. 2012;1:1-4.

6. Pan L, Mu M, Yang P, Sun Y, Wang R, Yang J, et al. clincial characteristics of covid-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. The American College of Gastroenterology. 2020;115:766-73.

7. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81-95.

8. Liu K, Fang Y, Liu W, Wang M, Ma J, Xiao W, et. Al. Clinical characteristic of novel coronavirus cases in tertiary hospital in Hubei Province. Chinese Medical Journal 2020;133(9).

9. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

10. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.

11. Walpole SC, McHugh R, Samuel J, Schmid ML. COVID-19 presenting as severe, persistent abdominal pain and causing late respiratory compromise in a 33-year-old man. BMJ Case Rep. 2020;13(6):e236030.

12. Amaral LT, Brito VM, Beraldo GL, Fonsenca EK, Yokoo P, Talans A, et al. Abdominal symptoms as initial manifestation of COVID-19: a case series. einstein (São Paulo). 2020;18:eRC5831.

13. Suryana DK, Simadibrata M, Renaldi K. Impact of COVID-19 on the gut: A review of the manifestations, pathology, management, and challenges. Indones J Intern Med. 2021;53(1):p96-104.

14. Abdullah M, Sudrajat DG, Muzellina VN, Kurniawan J, Rizka A, Utari AP, et al. The value of anal swab RT-PCR for COVID-19 Diagnosis in adult indonesian patients. BMJ Open Gastro. 2021; 8:e000590. doi:10.1136/bmjgast-2020-000590.

15. Dube MRS, Rounge TB, Fitzpatrick M, Christiansen IK, Ambur OH, Lagstro¨m S, et al. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping. PLoS ONE. 2021; 16(4): e0250426. DOI: https://doi.org/10.1371/journal.pone.0250426

16. Wu J, Liu J, Li S, Peng Z, Xiao Z, Wang X, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel med infect dis. 2020; 37: 101673.

17. Vetter P, Vu DL, Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of covid-19. BMJ. 2020; 369:m1470.

18. Papoutsis A, Borody T, Dolai S, Daniels J, Steinberg S, Barrows B, et al. Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing. Gut Pathog. 2021:13;7.

19. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. evidence for gastrointestinal infection of SARS-CoV2. Gastroenterol. 2020; 158 (6): 1831-33.

20. Bwire GM, Majigo MV, Njiro BJ, Mawazo A. detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis. J Med Viral. 2020; 1-7.

21. Zhao F, Yang Y, Wang Z, Li L, Liu L, Liu Y. The time sequences of respiratory and rectal viral shedding in patients with coronavirus disease 2019. Gastroenterology. 2020;159:p1158-6.

22. Kipkorir, V., Cheruiyot, I., Ngure, B., Misiani, M. and Munguti, J. Prolonged SARS-CoV-2 RNA detection in anal/rectal swabs and stool specimens in COVID-19 patients after negative conversion in nasopharyngeal RT-PCR test. J Med Virol. 2020;92:2328-31.

23. Li H, Ren L, Zhang L, Wang Y, Guo L, Wang C, et al. high anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):2707-14.

24. Sun M, Guo D, Zhang J, Zhang J, Teng HF, Xia J, et al. Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients. Future microbiol. 2020:10.2217/fmb-2020-0090.

25. Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020;92(11):2409-2411. doi:10.1002/jmv.26097

26. Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 2020;56(2):106051.

27. Du W, Zhang Y, Yu Y, Zhang R. D-dimer levels is associated with severe COVID-19 infections: A meta-analysis. Int J Clin Pract. 2021;00:e14031.

DOI: https://doi.org/10.13057/smj.v4i3.54197

Refbacks

  • There are currently no refbacks.